000 01302 a2200349 4500
005 20250515045730.0
264 0 _c20070720
008 200707s 0 0 eng d
022 _a0344-4325
024 7 _a10.1007/s00281-006-0045-0
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aUgen, Kenneth E
245 0 0 _aInjecting drugs of abuse and immunity: implications for HIV vaccine testing and efficacy.
_h[electronic resource]
260 _bSpringer seminars in immunopathology
_cNov 2006
300 _a281-7 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAIDS Vaccines
_xadministration & dosage
650 0 4 _aAnimals
650 0 4 _aClinical Trials as Topic
650 0 4 _aHIV Infections
_xcomplications
650 0 4 _aHTLV-I Infections
_xcomplications
650 0 4 _aHumans
650 0 4 _aIllicit Drugs
_xadverse effects
650 0 4 _aImmunity, Active
650 0 4 _aImmunity, Innate
650 0 4 _aLymphokines
_ximmunology
650 0 4 _aSubstance Abuse, Intravenous
_xcomplications
650 0 4 _aSubstance-Related Disorders
_xcomplications
700 1 _aNyland, Susan B
773 0 _tSpringer seminars in immunopathology
_gvol. 28
_gno. 3
_gp. 281-7
856 4 0 _uhttps://doi.org/10.1007/s00281-006-0045-0
_zAvailable from publisher's website
999 _c16681156
_d16681156